Medlive Technology (02192) Releases Monthly Return for October 2025, Issued Shares Increase by 534,500

Bulletin Express

Nov 04, 2025

Medlive Technology (02192) disclosed its Monthly Return for Equity Issuer for the period ended 31 October 2025. The company reported that its authorised share capital remained at 50,000,000,000 ordinary shares with a par value of USD 0.00001 each, amounting to a total of USD 500,000.

According to the filing, the total number of issued ordinary shares rose from 734,258,875 to 734,793,375. The increase of 534,500 shares resulted from the exercise of share options under the Pre-IPO Share Option Scheme, which raised RMB 203,110. The number of share options still available for exercise under the Post-IPO Share Option Scheme stands at 69,017,600 shares.

No changes to the number of treasury shares took place during the month. The company confirmed all necessary procedures and regulatory requirements for issuing the new shares have been fulfilled, and the newly issued ordinary shares rank pari passu in all respects with existing shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1179831478"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1179831478\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1179831478?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-04 17:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1179831478","market":"hk","top_or_hot":-1,"title":"Medlive Technology (02192) Releases Monthly Return for October 2025, Issued Shares Increase by 534,500","media":"Bulletin Express","content":"<p>Medlive Technology (02192) disclosed its Monthly Return for Equity Issuer for the period ended 31 October 2025. The company reported that its authorised share capital remained at 50,000,000,000 ordinary shares with a par value of USD 0.00001 each, amounting to a total of USD 500,000.</p>\n<p>According to the filing, the total number of issued ordinary shares rose from 734,258,875 to 734,793,375. The increase of 534,500 shares resulted from the exercise of share options under the Pre-IPO Share Option Scheme, which raised RMB 203,110. The number of share options still available for exercise under the Post-IPO Share Option Scheme stands at 69,017,600 shares.</p>\n<p>No changes to the number of treasury shares took place during the month. The company confirmed all necessary procedures and regulatory requirements for issuing the new shares have been fulfilled, and the newly issued ordinary shares rank pari passu in all respects with existing shares.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Medlive Technology (02192) Releases Monthly Return for October 2025, Issued Shares Increase by 534,500</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMedlive Technology (02192) Releases Monthly Return for October 2025, Issued Shares Increase by 534,500\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-04 17:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Medlive Technology (02192) disclosed its Monthly Return for Equity Issuer for the period ended 31 October 2025. The company reported that its authorised share capital remained at 50,000,000,000 ordinary shares with a par value of USD 0.00001 each, amounting to a total of USD 500,000.</p>\n<p>According to the filing, the total number of issued ordinary shares rose from 734,258,875 to 734,793,375. The increase of 534,500 shares resulted from the exercise of share options under the Pre-IPO Share Option Scheme, which raised RMB 203,110. The number of share options still available for exercise under the Post-IPO Share Option Scheme stands at 69,017,600 shares.</p>\n<p>No changes to the number of treasury shares took place during the month. The company confirmed all necessary procedures and regulatory requirements for issuing the new shares have been fulfilled, and the newly issued ordinary shares rank pari passu in all respects with existing shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02192","symbol_name":"医脉通","start_time":0,"source_url":"","article_id":"1179831478","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1179831478","pubTimestamp":1762249352,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Medlive Technology (02192) disclosed its Monthly Return for Equity Issuer for the period ended 31 October 2025. The company reported that its authorised share capital remained at 50,000,000,000...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02192":"医脉通"},"translate_title":"Medlive Technology(02192)发布2025年10月月报表已发行股份增加53.45万股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02192":1},"content_text":"Medlive Technology (02192) disclosed its Monthly Return for Equity Issuer for the period ended 31 October 2025. The company reported that its authorised share capital remained at 50,000,000,000 ordinary shares with a par value of USD 0.00001 each, amounting to a total of USD 500,000.\nAccording to the filing, the total number of issued ordinary shares rose from 734,258,875 to 734,793,375. The increase of 534,500 shares resulted from the exercise of share options under the Pre-IPO Share Option Scheme, which raised RMB 203,110. The number of share options still available for exercise under the Post-IPO Share Option Scheme stands at 69,017,600 shares.\nNo changes to the number of treasury shares took place during the month. The company confirmed all necessary procedures and regulatory requirements for issuing the new shares have been fulfilled, and the newly issued ordinary shares rank pari passu in all respects with existing shares.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}